Farallon Capital Partners, L.P. 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 12:11 pm Purchase | 2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,108,262 9.900% | 83,262 (+4.11%) | Filing |
| 2024-01-26 09:11 am Purchase | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,025,000 9.600% | 475,000 (+30.65%) | Filing |
| 2023-02-06 09:06 am Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 1,550,000 7.500% | 1,550,000 (New Position) | Filing |